GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Biotech Ltd (BOM:524717) » Definitions » PB Ratio

Titan Biotech (BOM:524717) PB Ratio : 3.48 (As of May. 15, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Titan Biotech PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-15), Titan Biotech's share price is ₹488.50. Titan Biotech's Book Value per Share for the quarter that ended in Dec. 2023 was ₹140.46. Hence, Titan Biotech's PB Ratio of today is 3.48.

The historical rank and industry rank for Titan Biotech's PB Ratio or its related term are showing as below:

BOM:524717' s PB Ratio Range Over the Past 10 Years
Min: 0.58   Med: 1.77   Max: 4.46
Current: 3.5

During the past 13 years, Titan Biotech's highest PB Ratio was 4.46. The lowest was 0.58. And the median was 1.77.

BOM:524717's PB Ratio is ranked worse than
64.09% of 1320 companies
in the Biotechnology industry
Industry Median: 2.52 vs BOM:524717: 3.50

During the past 12 months, Titan Biotech's average Book Value Per Share Growth Rate was 14.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 41.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 37.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 20.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Titan Biotech was 45.30% per year. The lowest was 6.00% per year. And the median was 10.75% per year.

Back to Basics: PB Ratio


Titan Biotech PB Ratio Historical Data

The historical data trend for Titan Biotech's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Biotech PB Ratio Chart

Titan Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 0.90 2.23 2.19 1.48

Titan Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.48 - 2.50 -

Competitive Comparison of Titan Biotech's PB Ratio

For the Biotechnology subindustry, Titan Biotech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Titan Biotech's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Titan Biotech's PB Ratio distribution charts can be found below:

* The bar in red indicates where Titan Biotech's PB Ratio falls into.



Titan Biotech PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Titan Biotech's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=488.50/140.462
=3.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Titan Biotech  (BOM:524717) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Titan Biotech PB Ratio Related Terms

Thank you for viewing the detailed overview of Titan Biotech's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Biotech (BOM:524717) Business Description

Traded in Other Exchanges
N/A
Address
903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi, IND, 110034
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.

Titan Biotech (BOM:524717) Headlines

No Headlines